|
Market Closed -
Nasdaq
23:00:00 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 144.43 USD | +0.68% |
|
-0.42% | -20.92% |
| 10-14 | Axsome Shows Valuation Disconnect Ahead of Q3, RBC Says | MT |
| 10-08 | RBC Trims Price Target on Axsome Therapeutics to $295 From $297, Keeps Outperform Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.68% | -0.42% | -21.67% | -33.74% | -20.92% | +6.99% | +131.90% | +275.14% | +2,055.67% | 7.57B | |
| +3.19% | +11.31% | +22.51% | +23.39% | +31.90% | +64.28% | +155.91% | +456.42% | +1,819.75% | 1,263B | |
| -0.73% | +3.56% | +3.20% | +6.57% | +32.01% | +44.65% | +84.17% | +67.73% | +135.54% | 658B | |
| +1.41% | +3.24% | +12.73% | +17.51% | +29.06% | +35.25% | +108.88% | +157.16% | +428.67% | 521B | |
| +0.42% | +3.20% | +15.55% | +14.08% | +22.91% | +55.81% | +72.50% | +13.94% | +77.32% | 391B | |
| +2.18% | +2.93% | +2.90% | +14.84% | +42.05% | +73.90% | +45.59% | +69.81% | +154.63% | 369B | |
| +1.12% | +4.52% | +11.52% | +5.67% | +22.06% | +34.76% | +58.24% | +76.86% | +90.03% | 307B | |
| +6.96% | +8.86% | +13.68% | +10.51% | +1.23% | +11.95% | +36.20% | +53.51% | +204.27% | 290B | |
| +1.15% | +6.09% | +10.56% | +20.99% | +42.38% | +56.15% | +82.25% | +125.16% | +230.13% | 252B | |
| +3.06% | +9.38% | +14.51% | +31.08% | +39.06% | +42.48% | +117.32% | +163.07% | +131.81% | 212B | |
| +2.21% | +2.29% | +5.09% | -13.18% | -18.19% | -15.78% | -60.69% | -24.44% | +119.55% | 175B | |
| +1.90% | +1.63% | +7.01% | +22.03% | +22.57% | +23.81% | -0.13% | -30.22% | -3.75% | 174B | |
| +3.50% | +6.67% | +6.90% | +17.14% | +23.28% | +31.33% | +54.34% | +202.21% | +636.73% | 142B | |
| +1.78% | +1.63% | +0.13% | -4.33% | +15.83% | +35.62% | +21.25% | +6.99% | +22.73% | 128B | |
| +1.40% | -0.62% | +16.49% | +16.16% | +21.25% | +22.58% | +118.42% | +378.44% | +682.09% | 116B | |
| +4.71% | +7.58% | +9.77% | +7.08% | -3.60% | -8.97% | -6.95% | -7.74% | +12.37% | 107B | |
| +2.26% | -2.06% | +1.26% | -3.96% | +1.67% | +4.18% | +27.28% | -1.63% | -8.31% | 99.63B | |
| +13.33% | +15.26% | +22.37% | +21.67% | +20.21% | +42.36% | +18.98% | +45.00% | +168.94% | 93.11B | |
| -0.47% | +10.80% | +15.14% | +304.45% | +651.85% | +716.35% | +191.89% | -35.77% | - | 88.52B | |
| +0.67% | +5.58% | +9.56% | +5.69% | +23.41% | +33.36% | +6.29% | -25.91% | +61.54% | 73.45B | |
| Average | +2.54% | +5.07% | +8.96% | +24.18% | +50.00% | +65.55% | +63.18% | +98.29% | +369.46% | 273.28B | |
| Weighted average by Cap. | +2.22% | +6.09% | +12.39% | +19.28% | +35.95% | +54.44% | +84.84% | +165.25% | +576.36% |
- Stock Market
- Stocks
- AXSM Stock
- Sector Axsome Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
